Northwest Biotherapeutics Limited
09103355
Healthy
- Negative net worth (-10)
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 11/01/2025
Due 25/01/2026
Industry
Officers
director · Since 19/11/2015
CHAIRMAN
AMERICAN · UNITED STATES · Age 70
Also on 2 other boards
Persons with Significant Control
Northwest Biotherapeutics, Inc.
4800, Montgomery Lane, Bethesda, 20814
Reg: 2926697 · Delaware, United States · Corporate
Notified 18/01/2024
Charges0 outstanding
SPICERS LIMITED
CompanyRankvs 241151+ SIC 68209 peers32
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
-£14.3M
Balance sheet strength
Cash
£4k
Cash in the bank
Net Current Assets
-£22.6M
Working capital
Current Assets
£671k
Current Liabilities
£23.2M
Fixed Assets
£8.2M
Debtors
£601k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 0.03 | -£4.0M |
| 2023 | 0.03 | -£6.5M |
| 2021 | — | -£1.4M |
| 2020 | — | -£1.5M |
| 2019 | — | -£878k |
Derived from filed accounts. Not audited figures.